G. Marshall Lyon - Concepedia

Author

G. Marshall Lyon

Also Known As

G LYON, G Lyon, G M LYON, G M Lyon, G Marshall Lyon, G Marshall Lyon III, G. Lyon, G. M. Lyon, G. Marshall Lyon, G. Marshall Lyon III

Publications

6.4K

Citations

H-Index

Concepts

All Affiliations

Emory University University of Pittsburgh Centers for Disease Control and Prevention Mayo Clinic University of Washington

About

G. Marshall Lyon is an author at Emory University specializing in medicine, infection control, and virology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	14	16	1.7K
2	Health Sciences	3	3	231
3	Public Health	2	2	96
4	Social Sciences	1	1	14
5	Biochemistry	1	1	41

G. Marshall Lyon

Publications

5.5K

Citations

H-Index

Page 1

	Year	Citations
Prospective Surveillance for Invasive Fungal Infections in Hematopoietic Stem Cell Transplant Recipients, 2001–2006: Overview of the Transplant‐Associated Infection Surveillance Network (TRANSNET) Database Dimitrios P. Kontoyiannis, Kieren A. Marr, Benjamin J. Park, Clinical Infectious Diseases	2010	1.4K
Outcomes of Kidney Transplantation in HIV-Infected Recipients Peter G. Stock, Burc Barin, Barbara Murphy, New England Journal of Medicine	2010	520
Persistence of Ebola Virus in Ocular Fluid during Convalescence Jay B. Varkey, Jessica G. Shantha, Ian Crozier, New England Journal of Medicine Viral PersistencePathogenesisViral PathogenesisImmunologyVirus Transmission	2015	464
Clinical Care of Two Patients with Ebola Virus Disease in the United States G. Marshall Lyon, Aneesh K. Mehta, Jay B. Varkey, New England Journal of Medicine VaccinationElectrolyte CorrectionLargest OutbreakMalariaHealthcare-associated Infection	2014	332
Human Ebola virus infection results in substantial immune activation Anita K. McElroy, Rama Akondy, Carl W. Davis, Proceedings of the National Academy of Sciences	2015	304
Norovirus Infectivity in Humans and Persistence in Water Scot Seitz, Juan S. León, Kellogg J. Schwab, Applied and Environmental Microbiology	2011	300
Norovirus Vaccine Against Experimental Human GII.4 Virus Illness: A Challenge Study in Healthy Adults David I. Bernstein, Robert L. Atmar, G. Marshall Lyon, The Journal of Infectious Diseases	2014	274
The Use of TKM-100802 and Convalescent Plasma in 2 Patients With Ebola Virus Disease in the United States Colleen S. Kraft, Angela Hewlett, Scott A. Koepsell, Clinical Infectious Diseases	2015	200
Randomized, Double-Blinded Clinical Trial for Human Norovirus Inactivation in Oysters by High Hydrostatic Pressure Processing Juan S. León, David H. Kingsley, Julia Montes, Applied and Environmental Microbiology Diagnostic VirologySeeded OystersViral PersistencePathogenesisHuman Norovirus Inactivation	2011	164
Effect of Preemptive Therapy vs Antiviral Prophylaxis on Cytomegalovirus Disease in Seronegative Liver Transplant Recipients With Seropositive Donors Nina Singh, Drew J. Winston, Raymund R. Razonable, JAMA	2020	163

Page 1